ticker-vbio

1 story
Coverage
3i Converted at $0.39. It Sold at $0.12.
Nasdaq

3i Converted at $0.39. It Sold at $0.12.

Since July, one investor has been turning preferred stock in Valion Bio into ordinary shares at a fixed price, then selling those shares on the open market for a fraction of it. Shareholders handed the board the power to do a reverse split — but that does nothing to the preferred stock still waiting